October 2025 FDA Recall Sucralfate by Amerisource Health Services Llc
D-0027-2026 - CGMP Deviations

This Class II drug recall was voluntarily initiated by Amerisource Health Services Llc on October 9, 2025 for the product Sucralfate. The FDA reported the reason for recall as cgmp deviations. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0027-2026

Reason for Recall
CGMP Deviations: The recalling firm filed for Chapter 11 on September 30, 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.
Initiated
10-09-2025
Reported
10-22-2025
Quantity
27,868 blister packs

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Amerisource Health Services LLC
Nationwide within the United States
Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 60687-695-01 - Carton NDC [60687-695-11- Unit Dose]

Batch or Lot Expiration Information

Lot# : 1017392, Exp. Date 01/31/2026; 1017415, Exp. Date 12/31/2025.

Affected Packages Involved in this Recall